Overview
- Editors:
-
-
Philip Furmanski
-
AMC Cancer Research Center, Denver, USA
-
Jean Carol Hager
-
AMC Cancer Research Center, Denver, USA
-
Marvin A. Rich
-
AMC Cancer Research Center, Denver, USA
Access this book
Other ways to access
Table of contents (31 papers)
-
-
Molecular Genetics of the RNA Tumor Viruses
-
- T. S. Papas, N. C. Kan, D. K. Watson, J. A. Lautenberger, C. Flordellis, K. P. Samuel et al.
Pages 1-13
-
- I. M. Verma, T. Curran, A. D. Miller, C. Van Beveren
Pages 14-24
-
- Berthe M. Willumsen, Douglas R. Lowy
Pages 25-40
-
- Jonathan A. Cooper, Kathy Gould, Tony Hunter
Pages 41-53
-
- Stuart A. Aaronson, Keith C. Robbins
Pages 54-66
-
- Kathleen Kelly, Brent Cochran, Charles Stiles, Philip Leder
Pages 67-75
-
Endogenous Retrovirus Sequences in Human Cells
-
- Robert Callahan, Ing-Ming Chiu, Toby Horn, Igbal Ali, Joan Robbins, Stuart Aaronson et al.
Pages 76-92
-
- A. B. Rabson, P. E. Steele, R. Repaske, M. A. Martin
Pages 93-107
-
- Catherine D. O’Connell, Maurice Cohen
Pages 108-115
-
Molecular Biology of Human Cancers
-
- Carlo M. Croce, Peter C. Nowell
Pages 116-126
-
- M. A. Lane, H. A. F. Stephens, M. B. Tobin, Kevin Doherty
Pages 127-132
-
- Nora Heisterkamp, John R. Stephenson, Gerard Grosveld, Annelies De Klein, John Groffen
Pages 133-150
-
- A. Thor, P. Horan Hand, D. Wunderlich, M. Weeks, A. Caruso, R. Muraro et al.
Pages 151-167
-
- Peter H. Duesberg, Michael Nunn, Nancy Kan, Dennis Watson, Peter H. Seeburg, Takis Papas
Pages 168-190
-
HTLV/LAV, T-Cell Leukemia and AIDS
-
- R. C. Gallo, G. Shaw, B. Hahn, F. Wong-Staal, M. Popovic, J. Schupbach et al.
Pages 191-205
-
- L. Montagnier, F. Barre-Sinoussi, D. Klatzmann, J. C. Gluckman, C. Rouzioux, F. Brun-Vezinet et al.
Pages 206-217
-
-
- Donald P. Francis, Cirilo D. Cabradilla, Paul M. Feorino, V. S. Kalyanaraman
Pages 232-239
-
About this book
We stand today on the threshold of a new understanding of cancer. Primarily through the powerful tools of molecular biology, unified hypotheses explaining the origins of the disease are emerging and rapidly being validated. This volume, which presents the latest findings from laboratories throughout the world on the role of RNA tumor viruses in cancer, is a celebration of these achievements and a prediction of further progress leading ultimately to the control of the disease. It is important in this context to recall the natural history or life cycle of RNA cancer virology. From the earliest days of the science, when viruses were first recognized as distinct biologic agents of etiologic significance, their role in cancer was proposed and hotly debated. The critical early discoveries, even those made as recently as 25 years ago, were met with rejection; not skepticism or cautious restraint, but outright rejection. During the 60's, there was a gradual acceptance of the association between viruses and cancer, the result of landmark studies in experimental systems, and this led to a frenzy of activity in the field. There followed another period of doubt and uncertainty, due to the difficulty in attempting to apply directly, and in retrospect inappropriately, the tenets of infectious disease to human cancers, only to have the field resurrected, revitalized and redirected by the explosion of progress in molecular biology and genetics.